Open access
Aug 2026
PSMB5-centered immunotherapy resistance signature predicts prognosis and drives CD8+ T cell exclusion in lung adenocarcinoma
The SuperPC based IRRG score robustly predicts prognosis and immunotherapy response in LUAD, representing both a predictive biomarker and a promising target for combination with PD 1 blockade.
L. Lin, F. Zheng, Y. Sun et al.
· medRxiv · 0 citations